Improving animal disease testing with faster molecular equipment
Acquisition of two superfast equipment for molecular testing in UI VDL
This study is working to speed up tests for animal diseases at the University of Illinois, so veterinarians can get faster results and help pets and livestock stay healthy more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11075622 on NIH RePORTER |
What this research studies
This research aims to enhance the efficiency of molecular testing for animal diseases at the University of Illinois Veterinary Diagnostic Laboratory (UI VDL). By acquiring superfast nucleic acid extraction and real-time PCR machines, the laboratory will be able to provide quicker test results, which is crucial for timely diagnosis and response to animal health issues. The project focuses on improving the quality of testing services for various animal diseases and routine surveillance efforts. This advancement will support veterinarians and animal health professionals in making informed decisions more rapidly.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include veterinarians and animal owners seeking rapid diagnostic services for their animals.
Not a fit: Patients who may not receive benefit from this research include those with human health conditions, as the focus is solely on veterinary diagnostics.
Why it matters
Potential benefit: If successful, this research could significantly reduce the time it takes to diagnose animal diseases, leading to faster treatment and improved animal health outcomes.
How similar studies have performed: Other research has shown success with similar rapid molecular testing approaches in veterinary diagnostics, indicating a promising avenue for improving animal health management.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Wang, Leyi — University of Illinois at Urbana-Champaign
- Study coordinator: Wang, Leyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.